NORML

MAY 26, 2020

Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs. Additional information regarding cannabinoids and pain appears online h ere.

Clinical Trials 261

Clinical Trials Chronic Pain Cannabinoids Patients 261

MMJ Recs

DECEMBER 10, 2023

While some states have embraced the therapeutic potential of cannabis and established robust medical marijuana programs, others lag behind, leaving patients without access to a potentially life-changing treatment. Disparities in access are primarily driven by the differing state regulations and policies surrounding medical marijuana.

Access 97

Access Marijuana Treatment Patients 97

Americans for Safe Access

DECEMBER 3, 2021

The latest issue of the ASA Activist Newsletter has the news you need to stay informed and be an effective advocate. You'll also find a link to the new issue of Cannabis Patient Care Magazine, a free benefit to ASA members, that this month features important information about coping with breast cancer treatment.

Events 246

Events Treatment Hemp Patients 246

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “This year, my focus was on program improvements to further expand both access and therapeutic value to benefit the health and well-being of all Virginians.”

Law 260

Law Patients Access Oil 260

Veriheal

AUGUST 15, 2022

In their recently published study, titled “The Effects of Consuming Cannabis Flower for Treatment of Fatigue,” the UNM researchers proved that the Cannabis sativa plant instantly reduced feelings of fatigue in most consumers. The sessions were logged by a total of 1,224 people who had access to the app.

Treatment 102

Treatment Research and Development Sativa Cannabinoids 102

NORML

JUNE 11, 2019

Patients diagnosed with chronic pain and other debilitating conditions typically reduce, or in some cases, eliminate their use of opioids following their enrollment in state-sanctioned medical cannabis access programs. Several peer-reviewed studies now document this trend. These conclusions are hardly unique. percent versus 44.8

Chronic Pain 188

Chronic Pain Programs Patients Access 188

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Americans for Safe Access

APRIL 23, 2018

This week, we submitted comments relating to the efficacy and medical usefulness of cannabis as a medical treatment. These comments will help inform the response of the United States to the World Health Organization in potentially reclassifying cannabis.

Food 189

Food Treatment Cannabis 189

NORML

MAY 21, 2019

.” Researchers concluded, “CBD’s potential to reduce cue-induced craving and anxiety provides a strong basis for further investigation of this phytocannabinoid as a treatment option for opioid use disorder.” In clinical models, CBD administration has been shown to reduce cravings for tobacco. .'”

Clinical Trials 193

Clinical Trials CBD History Data 193

Cannabis Law Report

JULY 28, 2021

president and CEO of MJH Life Sciences™, parent company of Cannabis Patient Care ™ “We are thrilled to partner with Americans for Safe Access because we share their passion for education and for helping as many patients as we can.”.

Access 81

Access Patients Education Treatment 81

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. For further information, please visit zambon.com.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Project CBD

NOVEMBER 11, 2023

And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. Dr. Weil: Yes, first of all, there’s been a big demand for information about cannabis from our Fellows, the people in our programs, they want to learn about it.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

MMJ Recs

JULY 9, 2024

Traditional treatments, while helpful to some extent, often come with limitations and side effects that can further burden individuals already dealing with a debilitating disease. Medical marijuana has emerged as a promising alternative treatment option for managing symptoms associated with MS.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

MMJ Recs

JUNE 9, 2024

West Virginia’s medical marijuana program was established to provide patients with qualifying medical conditions access to medical cannabis as an alternative treatment option. In this guide, we’ll break down everything you need to know to start accessing medical marijuana in West Virginia.

Access 52

Access Marijuana Patients Programs 52

Cannabis Law Report

AUGUST 23, 2021

Medicinal Cannabis Access Data Dashboard. To improve transparency and data accessibility, the TGA publishes de-identified data on the number of unapproved medicinal cannabis products accessed through the Special Access Scheme (SAS). Medicinal cannabis Special Access Scheme category B data. 19 August 2021.

Data 105

Data Access Medicine Patients 105

Cannabis Law Report

NOVEMBER 9, 2020

09 Nov 2020 Medicinal Cannabis And Treatment Access. The information below has been prepared in conjunction with our partner, Little Green Pharma. They write. Claiming … Read More. The post Australian Insurer HIF Provides Coverage For Medical Cannabis first appeared on Cannabis Law Report.

Treatment 98

Treatment Access Medicine Cannabis 98

LifeCannMD

APRIL 28, 2025

The conventional treatments weren’t appealing, and here was something he could make himself, based on actual research. Instead, he wanted everyone to have access to it. When cancer treatments leave you hugging the toilet bowl, unable to eat, struggling just to get through each daycannabis can be a lifeline.

History 82

History Chronic Pain Research and Development Oil 82

MMJ Recs

NOVEMBER 15, 2023

With the availability of MMJ dispensaries across Pennsylvania, patients have greater access to this natural remedy. This guide provides essential information including details on Pennsylvania MMJ dispensaries, the process of obtaining medical marijuana, and the program’s patient guide.

Access 52

Access Dispensary Programs Patients 52

Cannabis Chronicles

MAY 22, 2019

The partnership between the land grant institution in Pullman and the Tacoma-based native tribe is intended to create a standard to evaluate treatment plans at a natural healing clinic the Puyallups opened in October, and to determine the effectiveness of the drug as an alternative to opioids in managing pain.

Medicine 140

Medicine Research and Development Data Collective 140

MMJ Recs

OCTOBER 23, 2023

If you’re interested in exploring the world of MMJ in Oklahoma, this guide will walk you through the process of accessing MMJ, eligibility criteria, the application process, qualifying conditions, dispensaries, laws, patient rights, doctor recommendations, and the card application process.

Access 52

Access Chronic Pain Conditions Dispensary 52

NORML

JULY 23, 2019

After a long day of meetings and presentations, what republican policymakers seemed to be continuously asking for was evidence, proof, more information and testimony about the efficacy of cannabis for medicinal purposes in particular. Before beginning treatment with CBD oil, she was on six prescription medications.

Advocacy 122

Advocacy Education Oil Treatment 122

MMJ Recs

NOVEMBER 8, 2023

In recent years, a significant shift has occurred in Ohio’s approach to healthcare, with the introduction of medical marijuana (MMJ) marking a new era of treatment options for patients in the state. Dispensaries are strategically located throughout the state to enhance patient access and convenience.

Access 52

Access Chronic Pain Conditions Patients 52

MMJ Recs

NOVEMBER 22, 2023

Illinois dispensaries play a pivotal role in providing patients with access to medical marijuana, offering a range of products to address various health conditions. The physician will evaluate the patient’s medical history and determine if medical marijuana is a suitable treatment option. Image by Pfüderi from Pixabay.

Access 52

Access Dispensary Patients Programs 52

Illinois News Joint

FEBRUARY 8, 2023

The collaboration will allow us to combine our resources to better inform the public about issues and concerns Illinois medical patients have with the Compassionate Use of Medical Cannabis Program Act and Cannabis Regulation and Tax Act. To help facilitate this endeavor, we have partnered with Modern Compassionate Care.

Patients 98

Patients Treatment Environment Conditions 98

United Patients Group

NOVEMBER 21, 2023

Traditional treatments with prescription medications can sometimes be insufficient or accompanied by undesirable side effects, leaving patients in search of alternative methods for pain relief. To access medical cannabis for chronic pain management: 1.

Chronic Pain 105

Chronic Pain Strains Patients Marijuana 105

MMJ Recs

AUGUST 16, 2024

Traditional treatments include eye drops, oral medications, laser treatment, and surgery. This article explores the potential of medical marijuana for glaucoma treatment, focusing on its benefits, risks, and legal considerations. Several studies have shown that cannabinoids, the active compounds in marijuana, can lower IOP.

Treatment 111

Treatment Marijuana THC Strains 111

Cannabis Law Report

JULY 29, 2021

These assets include 5 addiction treatment clinics across the province of Alberta that have conducted over 35,000 patient visits during the past 12 months. Each clinic employs a highly educated and specialized team of dedicated physicians, nurses and therapists working in unison with patients to ensure treatment goals are achieved.

Chronic Pain 105

Chronic Pain Treatment Therapy Patients 105

Veriheal

MARCH 27, 2025

With Nelson promising to lower product costs if the bill is passed, it would make medical cannabis more affordable and accessible for patients. Senate File 46 would expand access to medical cannabis for Iowans. Patients and prospective patients may contact the Iowa Department of Public Safety at (515)-725-6230 for more information.

Chronic Pain 72

Chronic Pain Patients THC Programs 72

Cannabis Law Report

JULY 22, 2021

A master distribution agreement has been signed with My Green Planet, a leading global agricultural supply group, giving Sporeo access to approximately 7,000 retailers across North America, Australia, and Europe. Levitee Labs aims to catalyze access to compounds and alternative medicines that enhances the wellbeing of society.

eCommerce 105

eCommerce Therapy Media Access 105

Veriheal

NOVEMBER 9, 2023

Traditional treatments for these conditions often involve medication, physical therapy, or more invasive interventions like surgery. Refractory pain refers to pain resistant to traditional treatment approaches such as medication, physical therapy, or surgery. Especially in the case when other treatments have failed.

Treatment 111

Treatment Therapy Research and Development THC 111

Canna Care Docs

NOVEMBER 4, 2024

cannabis has been used medicinally as a treatment for pain and other ailments. Today, you can explore personalized treatment plans to aid your distinctive needs. We’ll break down each of these critical aspects to help you make informed decisions about chronic pain management options. Medicine and orthopedic concept.

Chronic Pain 111

Chronic Pain Nerve Pain Treatment Cannabinoids 111

LifeCannMD

JANUARY 31, 2025

Autoimmunity Reviews – “ Cannabis-Based Medicine in Inflammatory Disorders “: A 2023 multicenter study demonstrated reduced cytokine production in patients using prescribed cannabis treatments, suggesting potential benefits for managing autoimmune inflammation. This highlights the importance of personalized medical guidance.

Conditions 97

Conditions Research and Development Treatment Patients 97

MMJ Recs

FEBRUARY 6, 2024

In the ever-evolving landscape of medical marijuana, accessing cannabis through a dispensary in New Jersey can be both empowering and complex. As the state’s medical cannabis program expands, consumers need to be well-informed about dispensary dos and don’ts. Be patient and considerate of staff and other patients.

Access 52

Access Dispensary Marijuana Education 52

Project CBD

DECEMBER 31, 2022

In recent years, psilocybin and MDMA have been explored as potential treatments for post-traumatic stress disorder, but somewhat more quietly so has cannabis. In fact, according to a few quick searches of PubMed, cannabis has a longer and richer association with PTSD in the scientific literature than any psychedelic.

Sleep 130

Sleep Patients Treatment Cannabis 130

CannaMD

AUGUST 6, 2020

As one of Florida’s largest networks of medical marijuana physicians, CannaMD now encourages state legislators to take the next step and extend this access to visiting patients who have legally qualified for medical marijuana treatment in their home state. MORE INFORMATION. Click to Sign Petition. PROBLEM IN PRACTICE.

Law 116

Law Marijuana Treatment Patients 116

Cannabis Law Report

JULY 24, 2021

This expansive patent would allow Mydecine to scale its coverage in drug development research in lieu of promising discoveries and FDA-approval progress for novel therapeutics, including granting Breakthrough Therapy Designation to MDMA for the treatment of PTSD in recent years. For more information, please contact: Media Contacts.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105